Nachrichten zur Eli Lilly & Co. Aktie

Eli Lilly: Neuer 1 Bio. USD-Gigant! Abnehmmedikamente treiben das Pharma-Schwergewicht zu neuen Höhen!

Die Angst geht um an den US-Börsen. Der Fear & Greed Index rutschte zuletzt unter 10 und erreichte ein Level…

Billionaire Stanley Druckenmiller Dropped Nvidia, Palantir, and Eli Lilly Over the Past Year and Just Bought the 2 Cheapest Magnificent Seven Stocks.

These Magnificent Seven players are well-positioned to benefit in the AI boom.…

Eli Lilly: The Weight-Loss Leader With More Upside If Execution Holds

…

When Investors Panic, I Buy Eli Lilly

…

AKTIE IM FOKUS 2: Eli Lilly knackt Marke von 1 Billion Dollar Börsenwert

(neu: Aktienkurs aktualisiert) NEW YORK (dpa-AFX) - Als erstes Pharmaunternehmen hat Eli Lilly…

AKTIE IM FOKUS: Eli Lilly knackt nach Rally Marke von 1 Billion Dollar Marktwert

NEW YORK (dpa-AFX) - Als erstes Pharmaunternehmen hat Eli Lilly am Freitag mit dem Börsenwert…

Eli Lilly hits $1 trillion market value, a first for a health-care company

The pharmaceutical giant Eli Lillys stock has been riding the skyrocketing demand for its weight loss injection Zepbound and diabetes…

Lilly becomes first drugmaker to join trillion-dollar club on weight-loss demand boom

Eli Lilly hit $1 trillion in market value on Friday, making it the first drugmaker to enter the exclusive club…

Heres Why Eli Lilly (LLY) is a Strong Momentum Stock

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Heres why…

Novo, Lilly collaborate with Waltz Health to sell weight-loss drugs directly to employers

Digital health company Waltz Health said on Friday it has launched a program to offer popular weight-loss drugs from Novo…

Eli Lilly first healthcare company to hit $1T market capitalization

Eli Lilly and Co (NYSE:LLY) briefly reached a market capitalization of $1 trillion during trading on Friday, making it the…

Analysts get more bullish on this non-tech stock

The market has been swinging recently, with the S&P 500 index down 1.5% and the Nasdaq Composite down more than…

Heres Why Eli Lilly (LLY) is a Strong Growth Stock

Whether youre a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top…

Head and Neck Squamous Cell Carcinoma Market Research Report 2025-2035: Sanofi, Sun Pharma, and Eli Lilly Lead Through the Development of New Drugs, Clinical Trials, Combination Treatment Strategies

The global head and neck squamous cell carcinoma market is set for steady growth, driven by advancements in treatment options,…

Missed Out on Eli Lilly? 2 Healthcare Stocks With Big Catalysts on the Horizon.

These stocks both have advanced in the double-digits in recent months.…

Why Big Pharma Wont Quit the Diet. Who Will Win the Next Weight Loss Battle?

The next generation of weight loss drugs will hit the market in 2026. Eli Lilly and Novo Nordisk are racing…

Novo Nordisk cuts direct-to-consumer prices for Wegovy, Ozempic to $349 a month

The announcements come days after President Donald Trump struck deals with Novo Nordisk and Eli Lilly to make their GLP-1s…

Eli Lilly and Novo Nordisk May Soon Sell Weight Loss Drugs on the Planned TrumpRx. Could This Further Boost the Healthcare Giants Stocks?

Investors will be watching what Trump makes happen.…

Prediction: This Will Be Wall Streets Next Trillion-Dollar Stock

Drugs for weight loss and diabetes are taking Eli Lilly to new heights.…

Notable analyst calls this week: Eli Lilly, Nvidia and Skyworks among top picks

…

Mangoceuticals Provides Clarification on Launch of Branded GLP-1 Weight-Management Programs

Dallas, Texas, Nov. 13, 2025 (GLOBE NEWSWIRE) -- Mangoceuticals, Inc. (NASDAQ: MGRX) (“Mangoceuticals” or the “Company”) is issuing…

1 Incredible Reason to Buy LLYs Stock in November

Eli Lilly struck a deal with President Donald Trump last week that could send the stock much higher.…

Eli Lilly stock tops $1,000 for the first time. Cramer says the next milestone is within reach

"People are beginning to realize maybe this thing is worth far more," CNBCs Jim Cramer says.…

Eli Lilly ist der bei GLP-1-Marktführer mit Erlösen von 125 Mrd. USD bis 2030. Warum die Aktie noch 50%iges Potenzial hat!

Der Kampf um die Krone bei GLP-1-Produkten tobt. Mit Eli Lilly zeichnet sich ein Gewinner ab. Eli Lilly untermauert seine…

Here are Wednesdays biggest analyst calls: Nvidia, Apple, Broadcom, Eli Lilly, AT&T, Carvana, Cava, Disney & more

Here are Wednesdays biggest calls on Wall Street.…

Lilly Up 18% in a Month: Should You Buy, Sell or Hold the Stock?

Eli Lilly stock jumps 18% in a month as strong Q3 results, upgraded guidance and rising demand for Mounjaro and…

Eli Lilly cuts surprising deals with upstart biotech players

Eli Lilly stock reached a new 52-week high on Nov. 10, up 4.7% and extending a month-long rally of 16%,…

Leerink upgrades Eli Lilly following landmark deal with U.S. government

Leerink Partners sees shares of Eli Lilly adding another 19% from here.…

Here are Mondays biggest analyst calls: Nvidia, Tesla, Apple, Disney, Sunrun, Carmax, Eli Lilly, MP Materials & more

Here are Mondays biggest calls on Wall Street.…

3 Fantastic Growth Opportunities for Eli Lilly That Go Beyond GLP-1 Drugs

For long-term investors, there are plenty of reasons to buy and hold Eli Lilly for not only years but decades.…

Eli Lillys Breakout Is Here - Growing GLP-1 Market Share

…

Wall Street Week | Mamdani’s Win, Tariffs Fight, Pediatrics, Protein Boom

This week, can Congress delegate its authority over trade and tariffs to the president? The Supreme Court questioned the Trump…

Prediction: Eli Lilly Will Be Worth More Than Berkshire Hathaway by 2030

It could become the first trillion-dollar pharmaceutical company in the process.…

Eli Lilly Strikes a Landmark Pricing Deal With the U.S. for Its Billion-Dollar Weight Loss Drugs. Heres What This Means for Investors.

Weight loss drugs generated about $10 billion for Lilly in the most recent quarter.…

dpa-AFX ProFeed